| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.32 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |